"The effectiveness of exogenous cellular therapies has been limited by the ability to efficiently and locally deliver cells to a region of interest. We have developed biological sutures, formed from fibrin microthreads, to overcome these delivery issues and demonstrated increased cell engraftment compared to the current gold standard. However, the cell seeding efficiency onto the sutures is low and during implantation cells are subjected to shear forces as the sutures are pulled through the tissue. As a result, cells go unused after seeding and an uneven distribution of cells from the entry point to exit of the suture. By adding cell attachment and adhesion promoters and increasing culture time we proposed to overcome these issues. We have developed a shear loading method to evaluate the changes in cellular adhesion. Either poly-l-lysine or vitronectin was used to coat sutures. Uncoated control and coated sutures were then seeded with 100,000 human mesenchymal stem cells (hMSCs) for 24hrs or control sutures were seeded for 48hrs. An in vitro shear stress model was created by spinning seeded sutures with a centrifuge. Cell number per unit length prior to and post spinning were compared. To compare the effect of modifications on cell morphology cells were qualitatively assessed and nuclear alignment was evaluated as a robust measurement for overall cellular angle. Control sutures were found to have 6,821±739cells/cm prior to spinning, while sutures modified with poly-l-lysine resulted in 4,226±1,003cells/cm and vitronectin had 19,604±1,829cells/cm (p<0.05 vs. control and poly-l-lysine). 48hrs seeding resulted in a cell number to 4,417±2,266 cells/cm. Spinning resulted in relative decreases in cell number for control and coated sutures. Cells remained attached after sutures were spun after increased incubation time. Cells aligned along the long axis of individual microthreads; the alignment on control sutures was significantly different from all modifications. There was no difference in alignment between modifications, although they were significantly different compared to cells grown on topographically flat tissue culture plastic. These results demonstrated increased cell seeding efficiency and cell number for vitronectin coated biological sutures and increased cell adhesion following increased incubation time. The combination of these two modifications may lead to increased quantity and more evenly distributed cells delivered to diseased tissues by increasing initial cell number, increasing cell engraftment, and increased resistance to shear."

Efficient delivery into cells is essential for many applications. However, cellular access of “cell-impermeable” molecules, such as drugs, sensors, proteins and oligonucleotides, can often be severely limited due to the plasma membrane which protects cells from unregulated influx of hydrophilic materials. In order to solve this issue, several physical techniques and bio-chemical products are today available. One of them is called peptoids (N-alkylglycines). These compounds are peptidomimetics which are resistant to enzymatic degradation, non-immunogenic and are readily prepared by an Fmoc chemical approach. Peptoids based on the "TAT"-peptide (RKKRRQRRR) offer rapid cellular uptake/delivery and low cytotoxicity. In this thesis, based on previous works using fluorescein-cationic peptoids, various fluorescent N-substitued glycines (lysine-like) were prepared by the monomer method followed by solid-phase synthesis. Their cellular uptakes in vitro into several cell lines (such as HeLa, B16F10, HEK293T and primary immune cells) were examined via flow cytometry and microscopy. The cellular delivery of small molecules mediated by the 9mer polymer achieved an efficient and rapid penetration. These results open up a vast number of applications for delivery of macromolecules using nonalysine-like peptoid. In order to demonstrate this ability, the nonalysinelike carrier was used to deliver various biopolymer molecules such as peptides, GFP protein and DNA (in collaboration with Dr. Stefano Caserta). In addition, thanks to the non-cytotoxicity of this cellular transpoter (MTT assays); experiments were carried out in vivo in mice using peptoids labelled near-infrared dyes. The first results have shown that the peptoid is not toxic for the mouse and does not block cell movements. These results allowed the use of 9mer-peptoid as a cellular tracking agent. Based on the development on antimicrobial peptides, the polylysine-like peptoid was also tested as an antibiotic. Recent experiments carried out in collaboration with Dr. Kevin Dhaliwal have revealed a new antimicrobial property of the peptoids. In vitro and in vivo studies have been carried out using both gram positive and negative bacteria. These results present a promising alternative to conventional antibiotics and antimicrobial peptides (AMPs).

A collection of twenty three selectively mono-protected di- and triamines, masked with the Boc, Fmoc or Ddiv protecting groups, were synthesised via continuous flow synthesis in a self-assembled meso-scale PTFE flow reactor. The continuous flow strategy offered direct access to the mono-protected compounds in good yields, especially in the case of the Fmoc carbamates which circumvented the use of another sacrificial protecting group. Two of the mono-Boc-protected carbamates were used as starting materials to generate N-alkylglycine monomers; synthesised via tandem mono-alkylation and Fmoc carbamation, linked by an in-line scavenging protocol using a silica-based trisamine scavenger resin. The final step of the monomer synthesis employed catalytic transfer hydrogenolysis using 20% Pd(OH)2/C and 1,4- cyclohexadiene. The three-step flow procedure gave access to two monomers, with one of them being a novel N-alkylglycine unit bearing a triethylene glycol bridge. The monomers were used as building blocks to assemble new oligo-N-alkylglycines (peptoids) via microwave-assisted solid phase synthesis. Three different types of peptoids were synthesised: (i) oligo-N-(6-aminohexyl)glycines (“standard” peptoids), (ii) oligo-N-{2-[2-(2-aminoethoxy)ethoxy]ethyl}glycines (“triethylene glycol” [TEG] peptoids) and (iii) hetero-oligomers of alternating “standard” and “TEG” monomers (“hybrid” peptoids). The peptoids were evaluated for their cellular permeability and cytotoxicity with HeLa, HEK-293 and CHO cells. All the peptoids were shown to be non-cytotoxic at 10 μM based on cell proliferation assays. In general, it was found that the cellular uptake of the hybrid peptoids outperformed their standard and TEG analogues. Flow cytometry and confocal microscopy results revealed that the hybrid nonamer had the highest cellular uptake efficiency of all the peptoids synthesised. At a concentration of 1 μM, it outperformed the second best molecular transporter (standard nonamer) by a factor of seven.

Peptide bilden eine einzigartige Klasse von Biomolekülen. Auf Grund ihrer komplexen Struktur sind sie in der Lage hochspezifisch an Zielmoleküle zu binden und können darüber hinaus bioaktive Eigenschaften aufweisen. In dieser Dissertation wurden verschiedene Anwendungen, für die biologisch aktive Peptide genutzt werden können untersucht und darüber hinaus die Konjugation ungeschützter Peptide an funktionelle Gerüstmoleküle betrachtet. Die spezifischen Bindungseigenschaften eines Hemagglutinin bindenden Peptids konnten durch deren multivalente Präsentation auf einem Polymer-Nanopartikel genutzt werden, um einen hochwirksamen Virus-Eintritts-Blocker zu synthetisieren. Außerdem wurde in dieser Dissertation eine neuartige chemoselektive Konjugation zwischen ungeschützten zyklischen Peptiden und Proteinen erforscht, basierend auf der Staudinger Phosphonite Reaktion. Die kovalente Bindung zwischen Proteinen und Peptiden ermöglichte die zellulären Aufnahme und zytosolische Verteilung des konjugierten Proteins. Die neuartige Staudinger induzierte Thiol Addition konnte darüber hinaus für die intramolekulare Makrozyklisierung von Peptiden eingesetzt werden, wodurch die biologische Aktivität der Peptide gesteigert wurde. Dies konnte anhand von zyklischen zellpenetrierenden Peptiden, als auch in der Stabilisierung der helikalen Struktur eines peptidischen Protein-Protein-Interaktions Inhibitors gezeigt werden. Des weiteren wurde eine bioreversible chemoselektive Konjugationsmethode untersucht, basierend auf der O-Alkylierung von Carbonsäuren, um eGFP mit zyklischen zellpenetrierenden Peptiden zu markieren. Erste Schritte zur Evaluierung der entstandenen Konjugate wurden unternommen. Zusammengenommen konnte die Vielfältigkeit bioaktiver Peptide in mehreren Anwendungen gezeigt werden, mit besonderem Augenmerk auf die Erweiterung der Konjugationsmethoden für ungeschützte Peptide an funktionale Trägermoleküle. / Synthetic peptides are a unique class of biomolecules. Due to their complex structure they can bind targets in a highly specific manner and can furthermore exhibit unique properties. Even though they are complex in structure, they are straightforward synthetically accessible. This thesis evolves around the many different aspects, in which biological active peptides can be used, from specific binders to cell penetration tags. Furthermore, the site specific and chemoselective conjugation of an unprotected peptide to a functional scaffold has been addressed. The binding properties of peptides could be used to generate a highly potent virus entry blocker from a viral-membrane-protein binding peptide, which was displayed multivalently on a polymeric nanoparticle. Furthermore, this thesis explored a novel chemoselective reaction, based on the Staudinger phosphonite reaction to conjugate cyclic peptides to eGFP. The covalent attachment of the peptidic ligand promoted efficiently the cellular uptake of protein and its cytosolic distribution. The novel Staudinger induced thiol addition cascade was further successfully used in an intramolecular reaction to macrocyclize peptides in order to induce bioactivity. This could be shown for the synthesis of cyclic cell penetrating peptides, as well as to stabilize the helical structure of a peptidic protein-protein interaction inhibitor. Furthermore, a bioreversible chemoselective conjugation based on a diazo building block, was used to label eGFP with cyclic cell penetrating peptides. First steps to evaluate the potency in vitro were undertaken. Taken together, the versatility of bioactive peptides was demonstrated in multiple applications and the tools to conjugate unprotected peptides to functional scaffolds was extended by the Staudinger induced thiol addition.

Antikörper und Antigen-bindende Proteine, die an Fluorophore, Tracer und Wirkstoffe konjugiert sind, sind einzigartige Moleküle, welche die Entwicklung wertvoller diagnostischer und therapeutischer Werkzeuge ermöglichen. Allerdings ist der Konjugationsschritt sehr anspruchsvoll und trotz intensiver Forschung noch immer ein bedeutender Engpass. Zusätzlich sind Antigen-bindende Proteine oftmals nicht dazu in der Lage, die Zellmembran zu durchdringen und im Zellinneren nicht funktionsfähig. Daher ist ihre Verwendung auf extrazelluläre Targets beschränkt, was eine bedeutende Anzahl wichtiger Antigene vernachlässigt. Beide Limitierungen bilden Kernaspekte dieser Arbeit. Mit Tub-tag labeling wurde ein neuartiges und vielseitiges Verfahren für die ortsspezifische Funktionalisierung von Biomolekülen und Antigen-bindenden Proteinen entwickelt, und so die Palette der Proteinfunktionalisierungen bedeutend erweitert. Tub-tag wurde erfolgreich für die ortsspezifische Funktionalisierung verschiedener Proteine und Antigen-bindender Nanobodies angewendet, die für konfokale Mikroskopie, Proteinanreicherung und hochauflösende Mikroskopie eingesetzt wurden. In einem weiteren Projekt wurden zellpermeable Antigen-bindende Nanobodies hergestellt und somit das schon lange Zeit bestehende Ziel, intrazelluläre Targets durch in vitro funktionalisierte Antigen-bindende Proteine zu visualisieren und manipulieren, erreicht. Hierzu wurden zwei verschiedene Nanobodies an ihrem C-Terminus cyclischen zellpenetrierenden Peptiden unter Verwendung von Expressed Protein Ligation funktionalisiert. Diese Peptide ermöglichten die Endozytose-unabhängige Aufnahme der Nanobodies mit sofortiger Bioverfügbarkeit. Mit Tub-tag labeling und der Synthese von zellpermeablen Nanobodies konnten wichtige Bottlenecks im Bereich der Proteinfunktionalisierung und Antikörperforschung adressiert werden und neue Tools für die biochemische und zellbiologische Forschung entwickelt werden. / Antibodies and antigen binding proteins conjugated to fluorophores, tracers and drugs are powerful molecules that enabled the development of valuable diagnostic and therapeutic tools. However, the conjugation itself is highly challenging and despite intense research efforts remains a severe bottleneck. In addition to that, antibodies and antigen binding proteins are often not functional within cellular environments and unable to penetrate the cellular membrane. Therefore, their use is limited to extracellular targets leaving out a vast number of important antigens. Both limitations are core aspects of the presented thesis. With Tub-tag labeling, a novel and versatile method for the site-specific functionalization of biomolecules and antigen binding proteins was developed expanding the toolbox of protein functionalization. The method is based on the microtubule enzyme tubulin tyrosine ligase. Tub-tag labeling was successfully applied for the site-specific functionalization of different proteins including antigen binding nanobodies which enabled confocal microscopy, protein enrichment and super-resolution microscopy. In addition to that, cell permeable antigen binding nanobodies have been generated constituting a long thought goal of tracking and manipulating intracellular targets by in vitro functionalized antigen binding proteins. To achieve this goal, two different nanobodies were functionalized at their C-terminus with linear and cyclic cell-penetrating peptides using expressed protein ligation. These peptides triggered the endocytosis independent uptake of the nanobodies with immediate bioavailability. Taken together, Tub-tag labeling and the generation of cell-permeable antigen binding nanobodies strongly add to the functionalization of antibodies and their use in biochemistry, cell biology and beyond.